Scinovex
articleTop 1% cited

Outcome of transphenoidal surgery for acromegaly and its relationship to surgical experience

Clinical Endocrinology · 1999 · Vol. 50(5) · pp. 561–567
AhmedElsheikhIrene StrattonPageAdamsWass

Abstract

Surgical treatment is a safe and effective treatment for acromegaly and remains the first choice of treatment for most acromegalic patients. The results of this centre compare favourably with series from other centres. We have demonstrated improved results, both in terms of post operative growth hormone values and pituitary function tests with time and increasing neurosurgical experience. We conclude that outcome for the surgical treatment for acromegaly is best achieved with one surgeon specialising in pituitary surgery. Improved operative outcome thus achieved has major cost implications and avoids the necessity for consideration of postoperative radiotherapy and the use of expensive growth hormone suppressing drugs in the postoperative period.

MeSH terms

AcromegalyAdenomaAdolescentAdultAgedClinical CompetenceFemaleHumansMaleMiddle AgedPituitary GlandPituitary NeoplasmsGrowth HormoneChi-Square DistributionTreatment Outcome
Citations
293
FWCI
10.91
field-weighted impact
References
17
Percentile
99%
vs. same field & year
Citations per year
References
Determinants of clinical outcome and survival in acromegaly
Clinical Endocrinology · 1994 · 564 citations
EPIDEMIOLOGY OF ACROMEGALY IN THE NEWCASTLE REGION
Clinical Endocrinology · 1980 · 467 citations
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.

Outcome of transphenoidal surgery for acromegaly and its relationship to surgical experience · Scinovex